Escudero Barrilero A, Platas A, Jiménez M, Ruiz C, Fernández A, Rodríguez Luna J M, Maganto E, Romero J
Arch Esp Urol. 1989 May;42(4):345-52.
We analyzed the course of 170 patients, 136 of whom underwent bilateral lymphadenectomy. Data was obtained to define N of the TNM classification in 126 patients. The remaining patients (10 whose pathologic work-up was unavailable; 32 who did not undergo lymphadenectomy) were classified as Nx. Metastasis was diagnosed during follow-up in 60% of those with positive lymph nodes. In our view, metastasis was already present in these patients prior to the surgical procedure. The survival rate is significantly higher for the patient group without lymphatic spread compared to the group with negative lymph nodes and Nx. Evaluation of the patient group without lymphatic spread revealed a higher survivorship for those who received 2,000 rads (24%) prior to cystectomy compared to those who received 4,500 rads (17%) and those who received no irradiation (12%). However, there is a lower incidence of metastasis for the patient group submitted to surgery alone (50%) compared to those that received preoperative radiotherapy (73% and 67% for those treated with 2,000 and 4,500 rads, respectively). Furthermore, preoperative radiotherapy did not reduce the mortality rate which was 83% for those who received no radiotherapy, 73% for those who received 2,000 rads, and 75% for those who received 4,500 rads. However, it may seem contradictory that a radiation dose of 2,000 rads appears to be more effective in these patients than a dose of 4,500 rads which is theoretically closer to the ideal dose for treatment of node involvement. Patients with positive lymph nodes must be treated with chemotherapy as soon as they have recovered from the surgical procedure since 3 out of 5 patients have undetected micrometastases.
我们分析了170例患者的病程,其中136例接受了双侧淋巴结切除术。获取了126例患者的资料以确定TNM分期中的N分期。其余患者(10例病理检查结果未提供;32例未接受淋巴结切除术)被分类为Nx。在随访期间,60%淋巴结阳性患者被诊断为发生转移。我们认为,这些患者在手术前就已存在转移。与淋巴结阴性和Nx组相比,无淋巴转移患者组的生存率显著更高。对无淋巴转移患者组的评估显示,膀胱切除术前行2000拉德放疗的患者生存率更高(24%),而接受4500拉德放疗的患者生存率为17%,未接受放疗的患者生存率为12%。然而,单纯接受手术的患者组转移发生率较低(50%),相比之下,接受术前放疗的患者组转移发生率分别为73%(2000拉德放疗组)和67%(4500拉德放疗组)。此外,术前放疗并未降低死亡率,未接受放疗患者的死亡率为83%,接受2000拉德放疗患者的死亡率为73%,接受4500拉德放疗患者的死亡率为75%。然而,看似矛盾的是,2000拉德的辐射剂量在这些患者中似乎比4500拉德更有效,理论上4500拉德更接近治疗淋巴结受累的理想剂量。淋巴结阳性患者一旦从手术中恢复就必须接受化疗,因为五分之三的患者有未被检测到的微转移。